Promotion of conidia aggregation in Aspergillus niger by cyclic AMP and 5'-GMP.
D000241:Adenosine / Q000494:pharmacology; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000249:Adenosine Monophosphate / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D001230:Aspergillus / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D003994:Bucladesine / Q000494:pharmacology; D002449:Cell Aggregation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D000242:Cyclic AMP / Q000494:pharmacology*; D006152:Cyclic GMP / Q000494:pharmacology; D006150:Guanine Nucleotides / Q000494:pharmacology*; D006151:Guanosine / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology
D006150:Guanine Nucleotides; D006151:Guanosine; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D003994:Bucladesine; D000255:Adenosine Triphosphate; D013806:Theophylline; D000242:Cyclic AMP; D006152:Cyclic GMP; D000241:Adenosine